Biotech Manufacturing is Booming with Growth of Biologics and Gene Therapies

Date Published07/05/2018
Author NameMark Terry
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Rubius Therapeutics
Parent companyRubius Therapeutics
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2018
Capital investment ($):155
City reshored to:Smithfield
State(s) reshored to:RI
If relevant, work nearshored to:-
Product(s) reshoredstem cells and stimulate them into red blood cells
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Manufacturing/engineering joint innovation (R&D), Under-utilized capacity
Government Incentive dollar amount:2.75 million in tax credits
Find Reshoring Articles